Paper · 17848629
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL and 5 others. Am J Physiol Endocrinol Metab, 2007. Cited by 214 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Papers, record 17848629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17848629
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastric Inhibitory Polypeptide | Major topic |
| Insulin Resistance | Major topic |
| Obesity | Major topic |
| Receptors, Gastrointestinal Hormone | Major topic |
| Adipokines | |
| Adipose Tissue | |
| Animals | |
| Anti-Obesity Agents | |
| Blood Glucose | |
| Body Weight | |
| Corticosterone | |
| Dietary Fats | |
| Eating | |
| Glucagon | |
| Glucagon-Like Peptide 1 | |
| Glucose Intolerance | |
| Incretins | |
| Insulin | |
| Lipids | |
| Liver | |
| Male | |
| Mice | |
| Motor Activity | |
| Muscle, Skeletal | |
| Pancreas |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by96
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,683,151 | Tirzepatide for obesity without diabetes: mechanistic insights, clinical evidence, and future directions. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42683151 | PubMed |
| 42,592,044 | Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications. | Antib Ther | 2026 | https://conductscience.org/library/papers/42592044 | PubMed |
| 42,240,123 | Recent developments in GPCR signalling in appetite regulation. | Biosci Rep | 2026 | https://conductscience.org/library/papers/42240123 | PubMed |
| 41,679,433 | GIPR signaling modulates PYY-induced hypophagia and malaise in rodents. | Mol Metab | 2026 | https://conductscience.org/library/papers/41679433 | PubMed |
| 40,806,228 | Associations of Serum GIP, GLP-1, and DPP-4 with Metabolic and Hormonal Profiles and Tobacco Exposure in Women with Polycystic Ovary Syndrome. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806228 | PubMed |
| 40,347,281 | Impact of chronic consumption of probiotics, oats, and apples on expression of genes related to bile acids, lipid, gut peptides, and inflammation in peripheral monocular cells - findings from the CABALA study. | Eur J Nutr | 2025 | https://conductscience.org/library/papers/40347281 | PubMed |
| 40,214,973 | Hormonal predictors of the insulin sensitive phenotype in humans. | Biomol Biomed | 2025 | https://conductscience.org/library/papers/40214973 | PubMed |
| 40,201,698 | The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40201698 | PubMed |
| 40,175,127 | Physiology and clinical applications of GIP. | Endocr J | 2025 | https://conductscience.org/library/papers/40175127 | PubMed |
| 40,166,681 | The role of GIPR in food intake control. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40166681 | PubMed |
1 to 10 of 96
See all 96 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17848629
GET https://conductscience.org/api/papers/v1/17848629/cited_by?page=2